Efavirenz appears to be associated with elevated suicide risk in START trial
Package of prophylaxis against infections reduces the risk of death for people starting HIV treatment very late
START analysis looks at who benefits most from immediate HIV treatment
Reducing clinic visits can support retention in HIV care, African studies show
Early HIV treatment: mothers say they need time to think
Women with HIV have higher risk of loss to follow-up and death after delivery
Once-daily raltegravir works as well as twice-daily for initial HIV treatment
Dolutegravir plus lamivudine dual therapy works well as initial HIV treatment
Earlier HIV treatment is not over-burdening health services
